Anti Cd47 Antibody. The in vivo antitumor effects of CD47 antibodies have thus far been demonstrated using antibodies that simply block the interaction of CD47 with .
Several experiments showed that antiCD47 monoclonal antibodies stimulate the preferential phagocytosis of leukemia stem cells by mouse .
A Novel Blockade CD47 Antibody With Therapeutic PubMed
CD47 blocking agents such as monoclonal antibodies targeting CD47/SIRPα could interrupt the interaction between cancer cells and macrophages .
FirstinHuman, FirstinClass Phase I Trial of the AntiCD47
A Trial of AK117 (AntiCD47 Antibody) in Patients With Acute Myeloid Leukemia The safety and scientific validity of this study is the .
A Trial of AK117 (AntiCD47 Antibody) in Patients With Acute
In a mouse model of lymphoma antiCD47 antibodies prevent lymphoma cell proliferation and prolong survival (95) Treatment with a CD47blocking .
Mouse Cd47 Antibody Mab1866 100 R D Systems
Journal of Hematology Targeting CD47 for cancer immunotherapy
A Novel Blockade CD47 Antibody With Therapeutic Potential for
Perspectives on antiCD47 antibody treatment for experimental cancer
CD47 Antibody (14047982) Thermo Fisher
CD47 Wikipedia
Potential New Cancer Immunotherapy: AntiCD47SIRPα Antibodies
a NextGeneration Humanized Development of AO176, AntiCD47
Advances in AntiTumor Treatments Targeting the CD47/SIRPα Axis
The antiCD47 antibody 5F9 is welltolerated in patients with solid tumors and lymphoma when administered using a priming and maintenance dose .